Atena Shojaie | Behavioral Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Ms. Atena Shojaie | Behavioral Neuroscience | Best Researcher Award

Ms. Atena Shojaie, Kerman university of medical sciences, Iran.

Atena Shojaie is a dedicated medical-surgical nursing professional with a Master’s degree from Kerman University of Medical Sciences. Her early academic journey was marked by a passion for integrating clinical care with research, particularly in neurology and rehabilitation. Over three years of working in critical care settings, including Neurology and ICU wards, she honed her clinical expertise while also serving as a valued clinical instructor. Her research focus on guided imagery as a therapeutic intervention for multiple sclerosis and MRI-induced anxiety has led to innovative practices currently in use at major hospitals. Atena’s academic contributions are beginning to gain recognition through citations and clinical adoption of her methods.

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Atena Shojaie began her journey in the field of healthcare with a strong academic foundation, earning a bachelor’s degree in nursing followed by a Master of Science in Medical-Surgical Nursing from Kerman University of Medical Sciences. Her early academic interests revolved around holistic patient care and neuro-rehabilitation, which laid the groundwork for her later clinical and research endeavors. During her postgraduate studies, she demonstrated a deep commitment to understanding patient needs—especially those facing neurological challenges—while also refining her clinical skills in hospital environments.

🏥 Professional Endeavors

In the span of just three years, Atena accumulated extensive experience working in several critical hospital wards, including Neurology, Neurosurgery, and the Intensive Care Unit (ICU). Her hands-on experience with acute and chronic conditions shaped her clinical intuition and enhanced her ability to manage complex patient cases. Parallel to her clinical work, she embraced the role of a clinical instructor, mentoring nursing and emergency medical students with a balance of academic rigor and compassionate teaching. This dual role of caregiver and educator reflects her deep-seated dedication to both practice and pedagogy.

🔬 Contributions and Research Focus

Atena’s research primarily centers on the intersection of psychological interventions and physical rehabilitation, with a particular emphasis on multiple sclerosis (MS). Her master’s thesis, “The Effectiveness of Guided Imagery on Walking and Balance Dysfunction in Patients With Multiple Sclerosis,” stands as a cornerstone of her academic work. The project demonstrated measurable improvements in gait and balance among MS patients and has since influenced ongoing clinical practices. Additionally, she completed a significant study on the “Anxiety of Patients Undergoing Magnetic Resonance Imaging (MRI),” showing how guided imagery can alleviate pre-procedure stress—further reflecting her commitment to patient-centered innovations.

🧠 Innovations in Mental Imagery

Atena Shojaie has been instrumental in translating academic research into practical tools for patient care. One of her notable innovations includes the creation of a guided imagery audio file, which is now regularly used in two major healthcare centers—Bahonar Hospital’s MRI department and Shafa Hospital’s MS Clinic. This therapeutic tool has not only improved the mental well-being of patients but also contributed to smoother clinical workflows, particularly in high-anxiety environments like radiology units.

📈 Impact and Influence

Although still early in her research career, Atena’s work has begun to gain scholarly recognition. With a citation index that includes three citations and an h-index of 1, her research is already laying the foundation for future studies in neuro-nursing and psychological rehabilitation. Her work continues to resonate with clinical teams and academics alike, especially those focused on non-pharmacological interventions for neurological conditions.

🏅 Accolades and Recognition

Atena’s clinical and research activities have earned her respect among her peers and mentors at Kerman University of Medical Sciences. While formal awards may still be on the horizon, her true recognition lies in the adoption of her guided imagery methods by major hospitals—an endorsement of both her scientific rigor and clinical insight. Her role as a trusted clinical instructor further affirms her reputation as a knowledgeable and compassionate professional.

🌟 Legacy and Future Contributions

With a solid foundation in research and hands-on care, Atena Shojaie is poised to make enduring contributions to the field of neuro-rehabilitative nursing. Her vision includes expanding the use of therapeutic mental imagery in broader hospital settings and conducting multi-center studies to further validate its effectiveness. As she continues her academic and clinical journey, her legacy will likely be defined by a thoughtful fusion of science, compassion, and innovation—paving the way for future advancements in holistic patient care.

Publication

 

  • Anxiety of Patients Undergoing Magnetic Resonance Imaging (MRI): The Effectiveness of Guided Mental Imagery
    Authors: A. Shojaie, H. Amiri, T. Dehesh, B. Bagherian
    Year: 2024

 

  • The Effectiveness of Guided Imagery on Walking and Balance Dysfunction in Patients With Multiple Sclerosis: A Randomized Controlled Trial
    Authors: B.B. Atena Shojaie, Hoda Kamali, Monir Sadat Nematollahi, Zahra Imani Goghary
    Year: 2025

 

✅ Conclusion

Atena Shojaie exemplifies the new generation of nurse-researchers who bridge the gap between evidence-based practice and compassionate patient care. Her work in guided mental imagery not only addresses physical dysfunction but also supports patients’ emotional and psychological needs. As she continues to expand her research and clinical impact, Atena is well-positioned to influence future standards in neuro-nursing and non-pharmacological therapy. Her legacy will likely be defined by innovation, empathy, and a relentless pursuit of better outcomes for patients with neurological conditions.

Mustafa Nazıroğlu | Cellular Neuroscience | Neuroscience Research Excellence Award

Posted on by Neuroscientists

Prof. Mustafa Nazıroğlu | Cellular Neuroscience | Neuroscience Research Excellence Award

Prof. Mustafa Nazıroğlu,  Suleyman Demirel University, Turkey.

Professor Mustafa Nazıroğlu is a distinguished scholar with dual doctorates in Physiology and Neuroscience. Beginning his academic journey at Fırat University and advancing to leadership roles at Süleyman Demirel University, he has become a global authority in the fields of oxidative stress, calcium signaling, and TRP ion channels. His research portfolio includes over 270 peer-reviewed articles and thousands of citations, showcasing a profound impact on cellular neuroscience. Beyond research, he has led major international congresses, served on editorial boards of top journals, and has been honored with numerous awards and fellowships in Europe, Asia, and North America.

Profile

Orcid

 

🎓 Early Academic Pursuits

Professor Mustafa Nazıroğlu embarked on his academic journey with a degree from the Faculty of Veterinary Medicine at Fırat University in 1991. Driven by a profound curiosity for physiological mechanisms, he pursued a Ph.D. in Physiology at the same institution, which he completed between 1992 and 1996. His academic ambitions later led him to earn a second Ph.D. in Neuroscience from Süleyman Demirel University (SDU) in 2018, reflecting his commitment to interdisciplinary scholarship and continuous learning.

🧠 Professional Endeavors in Neuroscience and Biophysics

Currently, Professor Nazıroğlu holds the position of Head of the Department of Biophysics and Neuroscience at SDU Medical Faculty. His professional path has been shaped by a deep dedication to academic leadership, having served in several key roles including department head, director of the Neuroscience Research Centre (NOROBAM), and chair of numerous international scientific congresses. Notably, he has successfully organized the biennial International World Congress of Oxidative Stress, Calcium Signalling and TRP Channels from 2006 to 2020, as well as the International Brain Research School series from 2015 to 2024. His influence has also reached global platforms, including service on the organizing committee for the TEMA-14 Congress in Hubei, China, in 2011.

🔬 Contributions and Research Focus

A prolific researcher, Professor Nazıroğlu has significantly advanced our understanding of oxidative stress, calcium signaling, apoptosis, and ion channel (TRP) physiology. His scientific output includes 274 international research articles, 19 review papers, and six book chapters, collectively amassing over 11,500 citations and earning him a Scopus h-index of 59. He has also contributed as an editorial and reviewing member for leading journals such as Biological Trace Element Research, Scientific Reports (Nature Publishing), Frontiers in Physiology, and Current Neuropharmacology, among others. His research has bridged cellular neuroscience with therapeutic strategies, making him a vital contributor to the global scientific discourse.

🏅 Accolades and Recognition

Throughout his career, Professor Nazıroğlu has received numerous national and international honors, celebrating his scientific achievements and global engagement. These include the NATO Research Fellowship (Germany), the Alexander von Humboldt Fellowship (Germany), and the Young Investigative Scientist Award (USA). He has also been recognized by the Turkish Scientific and Technological Research Council (TÜBİTAK), the Howard Hughes Medical Institute (USA), and was the recipient of the prestigious Khwarizmi International Award (Iran). His visiting professorships at institutions in the UK, Qatar, and Japan further underscore his international reputation and collaboration.

🌍 Impact and Influence

Professor Nazıroğlu’s impact extends beyond academic publishing and conference organization. As a mentor, speaker, and panel member, he has shaped the careers of young neuroscientists and fostered a collaborative global network of researchers in calcium signaling and oxidative biology. His participation in expert advisory boards and scientific panels illustrates the depth of his influence on both research policy and biomedical innovation.

📘 Legacy of Knowledge

With over three decades dedicated to science and education, Professor Nazıroğlu has built a lasting legacy grounded in scientific rigor and visionary leadership. His conferences and educational programs, especially the International Brain Research School, have become cornerstone events for knowledge exchange in neuroscience. He has laid a strong foundation for future advancements in TRP channel research and neurophysiology.

🚀 Future Contributions and Vision

Looking forward, Professor Nazıroğlu continues to guide critical research on cellular responses to oxidative stress and ion channel modulation. His forward-thinking approach, combined with an inclusive scientific philosophy, ensures that he remains a leading voice in shaping the next era of biomedical research. With ongoing collaborative projects and mentorship of emerging scholars, his work is poised to influence both clinical and theoretical frontiers for years to come.

Publication

 

  • Title: Vitamin D Supplementation Modulates Blood and Tissue Zinc, Liver Glutathione and Blood Biochemical Parameters in Diabetic Rats on a Zinc-Deficient Diet
    Authors: Kechrid, Z.; Hamdiken, M.; Nazıroğlu, M.; Flores-Arce, M.
    Year: 2023

 

  • Title: Low molecular weight heparin treatment reduced apoptosis and oxidative cytotoxicity in the thrombocytes of patients with recurrent pregnancy loss and thrombophilia: Involvements of TRPM2 and TRPV1 channels
    Authors: Dal, Y.; Nazıroğlu, M.; Özkaya, M.O.
    Year: 2023

 

  • Title: NMDA Receptor Activation Stimulates Hypoxia-Induced TRPM2 Channel Activation, Mitochondrial Oxidative Stress, and Apoptosis in Neuronal Cell Line: Modular Role of Memantine
    Authors: Kenan Yıldızhan; Mustafa Nazıroğlu
    Year: 2023

 

  • Title: Honey bee venom melittin increases the oxidant activity of cisplatin and kills human glioblastoma cells by stimulating the TRPM2 channel
    Authors: Kemal Ertilav; Mustafa Nazıroğlu
    Year: 2023

 

  • Title: Silver nanoparticles potentiate antitumor and oxidant actions of cisplatin via the stimulation of TRPM2 channel in glioblastoma tumor cells
    Authors: Yener Akyuva; Mustafa Nazıroğlu
    Year: 2023

 

  • Title: A novel antagonist of TRPM2 and TRPV4 channels: Carvacrol
    Author: Nazıroğlu, M.
    Year: 2022

 

  • Title: Amantadine Attenuated Hypoxia-Induced Mitochondrial Oxidative Neurotoxicity, Apoptosis, and Inflammation via the Inhibition of TRPM2 and TRPV4 Channels
    Authors: Öcal, Ö.; Coşar, A.; Nazıroğlu, M.
    Year: 2022

 

  • Title: Eicosapentaenoic acid enhanced apoptotic and oxidant effects of cisplatin via activation of TRPM2 channel in brain tumor cells
    Authors: Öcal, Ö.; Nazıroğlu, M.
    Year: 2022

 

  • Title: Paclitaxel Promotes Oxidative Stress–Mediated Human Laryngeal Squamous Tumor Cell Death through the Stimulation of Calcium and Zinc Signaling Pathways: No Synergic Action of Melatonin
    Authors: Kumbul, Y.Ç.; Nazıroğlu, M.
    Year: 2022

 

  • Title: Protective role of selenium on MPP⁺ and homocysteine-induced TRPM2 channel activation in SH-SY5Y cells
    Authors: Yıldızhan, K.; Nazıroğlu, M.
    Year: 2022

 

🧾 Conclusion

Through an outstanding blend of academic excellence, innovative research, and global collaboration, Professor Nazıroğlu has carved a legacy as a leading figure in neuroscience and biophysics. His efforts in organizing international platforms and mentoring young scientists reflect a career committed to advancing knowledge and fostering global scientific networks. With continued contributions and visionary leadership, he remains a driving force in shaping the future of cellular neurophysiology and therapeutic discovery.

Hao Lai | Clinical Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Prof. Dr. Hao Lai | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Hao Lai, Zhongshan Hospital, Fudan University, China.

Dr. Hao Lai is a distinguished cardiovascular surgeon and researcher, currently serving as Chief Physician at Zhongshan Hospital, Fudan University. With over 20 years of clinical expertise, he specializes in aortic and cardiovascular surgery. His academic achievements include a Ph.D. in Surgery from Fudan University and significant contributions to the study of epigenetic mechanisms in thoracic aortic dissection. As a principal investigator of nationally funded projects and co-author of influential publications, Dr. Lai combines scientific rigor with clinical innovation. He has also played a key role in medical education and device development through industry collaboration.

Profile

Scopus

 

🎓 Early Academic Pursuits

Dr. Hao Lai began his academic journey with a strong foundation in medical sciences, culminating in a Ph.D. in Surgery from the prestigious Fudan University. His early academic pursuits were marked by a deep interest in cardiovascular physiology and surgical intervention, which later matured into a specialized focus on aortic diseases. His time as a doctoral candidate not only equipped him with rigorous scientific training but also ignited his lifelong commitment to solving complex clinical problems through research.

🏥 Professional Endeavors

Currently serving as Chief Physician at Zhongshan Hospital, Fudan University, Dr. Hao Lai has accumulated over two decades of extensive clinical experience in cardiovascular and aortic surgery. His professional trajectory reflects a seamless integration of surgical excellence with academic leadership. At Zhongshan Hospital, a leading institution in China, he has spearheaded several clinical programs aimed at enhancing patient outcomes in cases of thoracic aortic dissection and other high-risk cardiovascular conditions.

🔬 Contributions and Research Focus

Dr. Lai’s research centers around the epigenetic mechanisms underlying thoracic aortic dissection, with a particular focus on histone modification and DNA methylation. He is the Principal Investigator of a major research project funded by the National Natural Science Foundation of China, which explores the role of H3K36me3 histone modification and DNMT3B-mediated gene body methylation in the pathogenesis of aortic dissection. His scientific efforts bridge molecular pathology with clinical implications, offering new perspectives on the diagnosis and treatment of life-threatening vascular disorders.

🏆 Accolades and Recognition

A respected voice in cardiovascular medicine, Dr. Hao Lai has co-authored numerous influential articles in high-impact journals such as Cardiovascular Research and Advanced Science. His h-index of 18, as listed on Scopus, reflects his consistent scholarly output and the wide academic acknowledgment of his work. In addition, his authorship of the textbook Practical Surgery (3rd Edition), published by People’s Medical Publishing House, stands as a testament to his educational contributions to the next generation of Chinese surgeons.

🧪 Impact and Innovation

Dr. Lai’s research has made a tangible impact on the understanding and treatment of aortic diseases. His investigation into the epigenetic regulation of vascular pathology has opened new avenues for targeted therapies. Moreover, his collaboration with MicroPort Endovascular MedTech demonstrates his commitment to translating research findings into real-world applications, particularly in the development and refinement of endovascular surgical devices.

🌍 Influence and Collaboration

Beyond his direct research and surgical contributions, Dr. Lai’s influence extends into collaborative domains, both nationally and internationally. His leadership in high-level research grants, clinical trials, and industrial partnerships positions him as a central figure in the evolving landscape of cardiovascular surgery. His collaborative spirit fosters innovation and promotes cross-disciplinary dialogue, essential in today’s complex medical research environment.

🔮 Legacy and Future Contributions

As Dr. Hao Lai continues his distinguished career, his legacy is being shaped not only by his surgical accomplishments but also by his contributions to medical science. His ongoing projects are likely to further clarify the molecular landscape of aortic diseases and inspire new therapeutic strategies. Looking ahead, Dr. Lai is poised to remain at the forefront of cardiovascular innovation, committed to improving patient care through a synthesis of research, education, and clinical practice.

Publication

 

Title: Prevalence and predictors of left atrial thrombus in patients with rheumatic atrial fibrillation undergoing cardiac surgery: a cross-sectional study
Authors: J. Cui, Y. Zhang, Y. Wang, Q. Ji, C. Wang
Year: 2025


Title: A novel open-vascular single-branched stent graft in total arch repair of type A aortic dissection one-year results of a prospective multicenter randomized controlled study
Authors: J. Gu, W. Zhang, L. Kang, H. Lai, C. Wang
Year: 2025


Title: Fibroblast Activation Protein Acts as a Biomarker for Monitoring ECM Remodeling During Aortic Aneurysm via 68Ga-FAPI-04 PET Imaging
Authors: C. Hu, H. Tan, Y. Zhang, X. Chen, L. Wang
Year: 2025


Title: Mitochondrial NAD+ deficiency in vascular smooth muscle impairs collagen III turnover to trigger thoracic and abdominal aortic aneurysm
Authors: J. Zhang, Y. Tang, S. Zhang, K. Zhu, W. Zhang
Year: 2025


Title: Correcting mitochondrial loss mitigates NOTCH1-related aortopathy in mice
Authors: Y. Tang, J. Zhang, Y. Fang, Y. Xu, W. Zhang
Year: 2025


Title: Exploration of 68Ga-FAPI-04 PET/MR in Chronic Type B Aortic Dissection
Authors: C. Hu, Y. Zhang, S. Qiu, H. Shi, L. Wang
Year: 2025


Title: Effects of postoperative glucocorticoids on mitigation of organ dysfunction in patients with type A aortic dissection: A randomized controlled trial
Authors: M. Luo, J. Luo, X. Xu, G. Tu, Z. Luo
Year: 2024


Title: Therapeutic results of three-dimensional aortic valve anatomic repair for regurgitant bicuspid aortic valve
Authors: J. Li, C. Wang, Z. Zuo, W. Ding, T. Hong
Year: 2024


Title: 68Ga-FAPI-04 Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Ascending Aortic Aneurysm
Authors: C. Hu, H. Tan, Y. Zhang, H. Lai, L. Wang
Year: 2024


Title: Sex-based outcomes after thoracic endovascular aortic repair: A systematic review and meta-analysis
Authors: Y. Zhang, Y. Zhang, Y. Wang, L. Wang, Q. Ji
Year: 2025

✅ Conclusion

Dr. Hao Lai’s career represents a powerful blend of surgical precision, scientific insight, and academic leadership. His work has advanced the understanding of aortic diseases at the molecular level while improving surgical outcomes for patients. As he continues to mentor, innovate, and lead research at the intersection of epigenetics and cardiovascular pathology, Dr. Lai’s contributions are set to leave a lasting legacy in both clinical practice and medical science.

 

 

Ali Esmaeilzadeh Pilehroud | Clinical Neuroscience | Neuroscience Academic Distinction Award

Posted on by Neuroscientists

Dr. Ali Esmaeilzadeh Pilehroud | Clinical Neuroscience | Neuroscience Academic Distinction Award

Dr. Ali Esmaeilzadeh,  Pilehroud Allameh Tabataba’i University, Iran.

Ali Esmaeilzadeh Pilehroud is a distinguished teacher and university professor at Allameh Tabataba’i University in Tehran, specializing in psychology with a strong focus on neuroscience and child cognition. Holding a Ph.D. and an international certificate in psychotherapy for children, he has seamlessly blended academic excellence with practical expertise. His career is marked by significant research projects, multiple influential publications, and a commitment to nurturing future psychologists. His work consistently bridges scientific innovation with educational impact, earning him recognition both nationally and internationally.

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Ali Esmaeilzadeh Pilehroud began his academic journey with a profound passion for understanding the human mind. He earned his Ph.D. in Psychology from the prestigious Allameh Tabataba’i University in Tehran, where his research laid a strong foundation for his future contributions to the fields of psychology and psychotherapy. Additionally, he obtained an international certificate specializing in psychology and psychotherapy for children, reflecting his early commitment to focusing on child development and mental health.

🏛️ Professional Endeavors

Following his academic accomplishments, Ali Esmaeilzadeh Pilehroud embarked on a dual career as a teacher and a university professor at Allameh Tabataba’i University, one of Iran’s leading institutions. His role bridges both education and mentorship, allowing him to mold the minds of future psychologists. His deep involvement in both theoretical and practical aspects of psychology demonstrates his dedication to merging academic excellence with real-world application.

🧠 Contributions and Research Focus

Ali Esmaeilzadeh Pilehroud’s research primarily revolves around neuroscience and child cognition, highlighting his interest in the biological and psychological foundations of development. He has successfully completed two major research projects exploring these domains, contributing valuable insights to the scientific community. His work emphasizes understanding how early neural and cognitive development can be supported through targeted psychological interventions, particularly benefiting children’s growth and mental wellness.

📚 Books and Publications

A testament to his scholarly dedication, Ali Esmaeilzadeh Pilehroud has authored five volumes of academic and professional books, each carrying its own ISBN. These publications enrich the fields of psychology and child development, providing important resources for both students and practicing professionals. His writings are characterized by their accessibility and depth, offering readers a thorough understanding of complex psychological concepts.

🏆 Accolades and Recognition

Throughout his career, Ali Esmaeilzadeh Pilehroud has earned recognition for his contributions to academia and child psychology. His research works have been cited by peers, showcasing their influence and relevance. Additionally, his international certification in psychotherapy further underscores his standing in the global psychology community, distinguishing him as a leader in child-focused psychological practices.

🌍 Impact and Influence

Ali Esmaeilzadeh Pilehroud’s influence extends beyond the classroom and research labs. By integrating neuroscience with child psychology, he has advanced new methods for fostering cognitive development in children. His approach encourages educational reforms and therapeutic practices that are informed by scientific research, ultimately benefiting countless young lives and shaping a more scientifically informed society.

✨ Legacy and Future Contributions

Looking to the future, Ali Esmaeilzadeh Pilehroud remains committed to expanding his research and educational impact. His legacy is built upon a solid foundation of scientific inquiry, educational mentorship, and contributions to child psychotherapy. With plans to pursue further innovative projects, he aims to continue inspiring the next generation of psychologists while deepening the global understanding of child cognition and development.

Publication

  • Title: Lack of association between interleukin-10 gene promoter polymorphisms with HIV susceptibility and progression to AIDS
    Authors: A. Ramezani, E. Kalantar, A. Aghakhani, M. Banifazl, M. Foroughi, et al.
    Year: 2015

 

  • Title: Evaluation of acquired HIV drug resistance among people living with HIV who have taken antiretroviral therapy for 9–15 months in 14 triangular clinics in Iran, 2015–2016
    Authors: M. Mohraz, K. Tayeri, H. Namdari Tabar, Z. Bayat Jozani, L. Sadeghi, et al.
    Year: 2019

 

  • Title: Different Degrees of Immune Recovery Using Antiretroviral Regimens with Vonavir or Zidovudine/Lamivudine/Efavirenz in HIV-Positive Patients Receiving First Line Treatment in Iran
    Authors: L. Sadeghi, S. Moallemi, R.A. Tabatabai, A. Esmaeilzadeh, S. Ahsani-Nasab, et al.
    Year: 2018

 

  • Title: Enhanced immune responses against HIV-1 with Adenovector (gag and tat) prime/protein boost regimen and GM-CSF injection
    Authors: N.H. Rouzbahani, S. Bayanolhagh, M. Gholami, A. Esmaeilzadeh, Z.B. Jozani, et al.
    Year: 2016

 

  • Title: Comparing Theory of Mind and Executive Functions in Obsessive Compulsive Disorder, Schizophrenia, and Normal Individuals
    Authors: نیکجو وکیل آباد, اسمعیل زاده پیله رود (Nikjoo Vakilabad, Esmaeilzadeh Pilerood)
    Year: (Not clear—year not given, but possibly recent.)

 

🖋️ Conclusion

Through a lifelong dedication to psychology, research, and teaching, Ali Esmaeilzadeh Pilehroud has made lasting contributions to child development studies and cognitive neuroscience. His legacy is not only evident in his scholarly books and research projects but also in the lives of the students and professionals he has mentored. Looking ahead, he continues to inspire and innovate, shaping the future of psychological science and fostering better mental health outcomes for children worldwide.

Nai-Bing Gu | Clinical Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Prof. Dr. Nai-Bing Gu | Clinical Neuroscience | Best Researcher Award

Dr. Gu Naibing is a distinguished Chief Physician in the Department of Neurology at Xi’an Central Hospital, specializing in neuroimmunology. He has made significant contributions to the understanding of neurological diseases, particularly those related to autoimmune and inflammatory conditions of the nervous system. As a Master’s degree supervisor and an active member of several professional committees, Dr. Gu has established himself as a leader in the fields of neurology and neuroimmunology. His research, clinical expertise, and involvement in medical organizations have earned him recognition and influence in the medical community. His work continues to have a lasting impact on both the treatment of neurological diseases and the education of future healthcare professionals.

Profile

Scopus

 

👨‍⚕️ Early Academic Pursuits

Dr. Gu Naibing embarked on his academic journey with a keen interest in neurology and medicine. After completing his medical degree, he pursued further studies in the specialized field of neurology, which led to the completion of his Master’s degree. Throughout his academic tenure, Dr. Gu consistently demonstrated a strong dedication to advancing his understanding of complex neurological conditions. His early academic endeavors set the foundation for a career focused on improving patient outcomes and advancing scientific knowledge in neuroimmunology.

💼 Professional Endeavors

Dr. Gu Naibing has established himself as a prominent figure in the field of neurology. As a Chief Physician in the Department of Neurology at Xi’an Central Hospital, he plays a vital role in diagnosing and treating a wide range of neurological disorders. Additionally, he serves as a Master’s degree supervisor, contributing to the training and development of the next generation of medical professionals. His professional network includes multiple roles in prestigious committees, such as the Neuroimmunology Professional Committee of the Shaanxi Provincial International Medical Exchange Promotion Association and the Neurology Branch of the Xi’an Medical Association.

🔬 Contributions and Research Focus

Dr. Gu’s research primarily focuses on neuroimmunology, the intersection of the immune system and neurological diseases. His work has advanced understanding in this field, particularly with regard to the mechanisms underlying autoimmune disorders affecting the nervous system. By contributing to a deeper understanding of brain diseases, Dr. Gu’s research has had significant implications for the development of more effective treatments for patients suffering from conditions such as multiple sclerosis, encephalitis, and other neuroinflammatory disorders. His focus on integrating immunological and neurological disciplines has been pivotal in pushing the boundaries of clinical research.

🏆 Accolades and Recognition

Throughout his career, Dr. Gu Naibing has earned several accolades and recognition for his outstanding contributions to the medical field. His involvement in various professional committees highlights his leadership and influence in the realm of neurology and neuroimmunology. As a standing committee member of the Neuroimmunology Group and the Neurology Professional Committee of the Shaanxi Health Care Association, Dr. Gu’s expertise and leadership are regularly sought after. His recognition extends beyond clinical practice, as he is frequently invited to contribute to national and international discussions on neurological care and research.

🌍 Impact and Influence

Dr. Gu Naibing’s influence extends beyond his clinical and research activities. Through his active involvement in professional organizations, he has had a profound impact on the development of neurology and neuroimmunology practices in China. His leadership in committees, particularly within the Shaanxi Medical Communication Association, has helped bridge gaps between medical professionals, facilitating the exchange of ideas and research findings. His dedication to fostering collaboration among medical communities has contributed to the enhancement of healthcare practices and the overall improvement of patient care.

🧠 Legacy and Future Contributions

As Dr. Gu Naibing continues his work, his legacy in the fields of neurology and neuroimmunology will undoubtedly inspire future generations of healthcare professionals. His commitment to advancing both clinical and research practices ensures that his contributions will have a lasting impact on the treatment of neurological diseases. Looking ahead, Dr. Gu is poised to continue making significant strides in neuroimmunology, with ongoing research and collaborations aimed at developing new therapeutic approaches. His future contributions promise to further shape the landscape of neurological healthcare, enhancing the lives of patients around the world.

🌟 Final Thoughts

Dr. Gu Naibing’s career has been defined by his passion for neurology, his commitment to advancing research, and his tireless efforts to improve patient outcomes. As a clinician, educator, and researcher, he has earned the respect and admiration of his peers, contributing significantly to the advancement of medical knowledge and patient care. With his continued dedication to the field, Dr. Gu’s legacy is sure to endure, influencing both the scientific community and the generations of healthcare professionals who follow in his footsteps.

Publication

  • Title: Effect of BMSCs overexpressing intelectin-1 on angiogenesis in rats with cerebral infarction
    Authors: B. Zhu, K. Guo, L. Zha, L. Chang, N. Gu
    Year: 2025

 

  • Title: Salivary duct carcinoma presenting with unilateral multiple cranial nerve lesions and concurrent intracranial metastasis: A case report
    Authors: B. Zhu, Q. Zhang, K. Guo, Y. Yang, X. Jia
    Year: 2025

 

Conclusion

Dr. Gu Naibing’s career is a testament to his dedication to advancing the field of neurology and neuroimmunology. His groundbreaking research, leadership in medical committees, and commitment to education have shaped the future of neurological care in China. With his continued focus on improving patient care and expanding scientific knowledge, Dr. Gu is poised to make lasting contributions that will positively impact both the medical field and the lives of countless patients. His legacy will inspire future generations of researchers and clinicians in the realm of neurology.

 

Michael Leoncio | Neuroscience & Education | Best Researcher Award

Posted on by Neuroscientists

Dr. Michael Leoncio | Neuroscience & Education | Best Researcher Award

Dr. Michael Leoncio, NIcklaus Childrne’s Hospital, United States.

Dr. Michael Leoncio is a dedicated pediatric critical care physician whose academic and professional journey reflects a deep passion for child health. Beginning with a dual degree in Chemistry and Physical Therapy, he went on to earn his D.O. from the New York College of Osteopathic Medicine. His clinical training took him from a pediatric residency in New Jersey to specialized fellowships at Miami Children’s Hospital, focusing on both general and cardiac pediatric critical care. Throughout his career, Dr. Leoncio has made significant contributions in the high-intensity environment of pediatric ICUs, shaping protocols, mentoring new clinicians, and improving outcomes for countless children.

Profile

Orcid

🎓 Early Academic Pursuits

Born in Hialeah, Florida, Dr. Michael Leoncio’s educational journey began with a strong dual foundation in Chemistry and Physical Therapy at the University of Miami, where he earned both his BHS and BA degrees. Driven by a passion for healing and science, he advanced to the New York College of Osteopathic Medicine, obtaining his Doctor of Osteopathy (D.O.) in 2004. These formative years were marked by his unwavering dedication to medicine and a growing interest in pediatric health, setting the stage for his future specialization in pediatric critical care.

🏥 Professional Endeavors

Following medical school, Dr. Leoncio completed a pediatric internship and residency at Newark Beth Israel Medical Center in New Jersey. His experiences under the mentorship of Dr. Josh Rosenblatt solidified his commitment to caring for children facing complex health challenges. He then pursued advanced fellowship training in Pediatric Critical Care Medicine from July 2007 to June 2010 at Miami Children’s Hospital, under Dr. Balaganghadar Totapally. Continuing his pursuit of excellence, he further specialized with an additional year as a Clinical Fellow in Pediatric Cardiac Critical Care Medicine, guided by Dr. Anthony Rossi. These rigorous training years provided Dr. Leoncio with extensive hands-on experience in managing critically ill children with cardiac conditions.

🔬 Contributions and Research Focus

Dr. Leoncio’s fellowship years were not only defined by clinical mastery but also by his engagement in cutting-edge pediatric and cardiac intensive care research. Working within high-acuity settings, he contributed to innovations in the care of neonates and children requiring intensive monitoring and support. His clinical insights have contributed to protocol advancements in cardiac intensive care, especially in the nuanced management of post-operative pediatric patients.

🏅 Accolades and Recognition

Throughout his academic and professional career, Dr. Leoncio has garnered recognition for his commitment to compassionate, evidence-based care. His peers and mentors have consistently praised his diligence, leadership qualities, and dedication to the field of pediatric critical care. These commendations reflect not only his technical expertise but also his empathetic approach to both patients and their families during the most vulnerable times.

Publication

  • Prevalence of Arginine Vasopressin Deficiency among Children and Adolescents Declared Dead by Neurologic Criteria
    Cesar Esteban Larancuent; Valandrea Merilan; Michael Leoncio; Juan Manuel Lozano; Balagangadhar R. Totapally | 2025

 

  • Epidemiology and outcomes of children with accidental hypothermia: A propensity-matched study
    Totapally A; Leoncio M; Beltramo F; Keith Meyer; Raszynski A; Totapally BR | 2017

 

  • Serial cardiac troponin concentrations as marker of cardiac toxicity in children with status asthmaticus treated with intravenous terbutaline
    Kalyanaraman M; Bhalala U; Leoncio M | 2011

 

  • Therapeutic hypercapnia enhances the inflammatory response to endotoxin in the lung of spontaneously breathing rats
    Norozian FM; Leoncio M; Torbati D; Keith Meyer; Raszynski A; Totapally BR | 2011

 

🏁 Conclusion

Driven by compassion, expertise, and a vision for innovation, Dr. Leoncio stands as a beacon in the field of pediatric medicine. His commitment to critical care continues to inspire those around him and set new standards for excellence in child health. As he looks to the future, his ongoing efforts promise to elevate pediatric intensive care—ensuring that every child, no matter how critically ill, receives the best possible chance at recovery and life.

Clotilde Guidetti | Neuropharmacology | Best Researcher Award

Posted on by Neuroscientists

Dr. Clotilde Guidetti | Neuropharmacology | Best Researcher Award

Dr. Clotilde Guidetti, Harvard Medical School, Massachusetts General Hospital, United States.

Clotilde Guidetti is an accomplished early-career physician-scientist specializing in Child and Adolescent Neuropsychiatry. With a classical foundation and medical training from the University of Genoa, she excelled academically, earning multiple merit awards and graduating Summa Cum Laude. She completed her specialized residency at the Catholic University of Rome, further refining her clinical expertise. Clotilde’s research focus lies in neurodevelopmental disorders, behavioral interventions, and psychopharmacology in pediatric populations. She has already demonstrated promise as an independent researcher through competitive grant submissions and award-winning conference presentations. Based in Boston, she is actively shaping a career that bridges clinical care and scientific innovation.

Profile

Scopus

 

🎓 Early Academic Pursuits

Clotilde Guidetti began her academic journey with a deep-rooted passion for understanding the human mind and behavior. She earned her High School Diploma in Classical Studies from the prestigious State High School Andrea D’Oria, an early indication of her strong intellectual curiosity and dedication to learning. This foundation in classical education provided her with a broad humanistic perspective that continues to inform her clinical and research approach. She then pursued her Medical Degree at the University of Genoa, where she graduated Summa Cum Laude in 2020. Her academic record was consistently marked by distinction, earning multiple Academic Merit Awards for clinical excellence during her medical studies.

🧠 Professional Endeavors

Following her graduation, Dr. Guidetti further specialized in the field of Child and Adolescent Neuropsychiatry through a rigorous residency program at the Catholic University of Rome. Completed in November 2024, her residency was also distinguished with Summa Cum Laude honors, reflecting both her clinical acumen and compassionate engagement with young patients. Her professional training combined intensive clinical work with scholarly research, preparing her to address complex neurodevelopmental and psychiatric disorders in children and adolescents.

🔬 Contributions and Research Focus

Dr. Guidetti’s primary research interests lie at the intersection of neurodevelopment, behavioral disorders, and psychopharmacology in pediatric populations. Her clinical insights are deeply enriched by her scientific inquiries, particularly those focused on the early diagnosis and personalized treatment of neuropsychiatric conditions. She has already begun shaping her independent research path, as seen in her recent submission for the Brain & Behavior Research Foundation Young Investigator Grant in January 2025. Her project, currently under review, reflects her growing reputation as an emerging scholar in the domain of pediatric neuropsychiatry.

🏅 Accolades and Recognition

Throughout her academic and clinical journey, Clotilde Guidetti has been the recipient of multiple honors that highlight her outstanding abilities. These include three Academic Merit Awards from the University of Genoa and a prestigious Erasmus Socrates Fellowship in 2017–2018, which broadened her training in an international context. In 2022, she received the Attilio Sabato Award from the Società Italiana di Neuropsicofarmacologia (SINPF) for the best poster presentation—an achievement that not only celebrated her communication skills but also her innovative scientific thinking in neuropsychopharmacology.

🌍 Impact and Influence

Though early in her career, Dr. Guidetti has already begun to leave a meaningful mark on the field of child and adolescent mental health. Her dual focus on clinical excellence and academic inquiry ensures that her work resonates both within medical communities and in the lives of the families she serves. With a practice grounded in empathy and scientific rigor, she exemplifies the new generation of clinician-scientists committed to transforming mental health care for the most vulnerable populations.

🧬 Legacy and Future Contributions

As she looks to the future, Clotilde Guidetti aims to expand her contributions to academic psychiatry through collaborative research, cross-disciplinary studies, and the mentorship of emerging professionals in the field. Her continued involvement in national and international research networks promises to amplify her influence, paving the way for innovative treatments and holistic models of care in pediatric neuropsychiatry. Her vision is firmly centered on early intervention, neurodevelopmental resilience, and the integration of clinical practice with cutting-edge neuroscience.

📚 Academic Footprint

Dr. Guidetti currently resides and practices in Boston, Massachusetts, where she continues to build her clinical and research profile. Her dual base—rooted in Italy and expanding into the United States—places her at the nexus of transatlantic collaboration. With each project and presentation, she further refines her expertise and extends her academic footprint, fostering a dynamic career defined by global engagement, intellectual integrity, and unwavering commitment to child and adolescent mental health.

Publication

  • Title: Antidepressants in the acute treatment of post-traumatic stress disorder in adults: a systematic review and meta-analysis

  • Authors: Guidetti, Clotilde; Feeney, Anna; Hock, Rebecca S.; Fava, Maurizio; Papakostas, George I.

  • Year: 2024

 

📝 Conclusion

Dr. Guidetti embodies the ideal of a compassionate clinician and rigorous academic, poised to make significant contributions to the future of child and adolescent mental health. Her career so far reflects a seamless blend of scholarly excellence, clinical sensitivity, and a drive to push the boundaries of understanding in neuropsychiatry. As she continues to expand her research and collaborative efforts globally, her work promises to influence both scientific discourse and practical approaches in mental health care—building a legacy rooted in evidence, empathy, and innovation.

 

Gilles Rode | Clinical Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Prof. Gilles Rode | Clinical Neuroscience | Best Researcher Award

Dr. Gilles Rode is a distinguished figure in the field of Physical Medicine and Rehabilitation (PMR), holding significant positions at both academic and clinical institutions in France. His career spans decades, with a strong foundation built on his dual M.D. and Ph.D., which paved the way for his pioneering work in neuroplasticity and motor rehabilitation. As the Head of the Department of Rehabilitation at Hôpital Henry Gabrielle and the Dean of the Faculty of Medicine Lyon-Est, he has contributed extensively to the development of rehabilitation practices, medical education, and research. Dr. Rode’s research focuses on understanding neurological recovery and enhancing rehabilitation techniques for patients with brain injuries, while his leadership roles in organizations like the French Society of Physical Medicine and Rehabilitation (Sofmer) and the European Academy of Rehabilitation and Physical Medicine underscore his impact on a global scale.

Profile

Scopus

 

Early Academic Pursuits 📚


Gilles Rode’s academic journey began with a strong foundation in medicine and physical rehabilitation, which led him to pursue a dual M.D. and Ph.D. This unique combination of clinical and scientific expertise laid the groundwork for his exceptional career. His training at esteemed institutions in France, particularly at Université Claude Bernard Lyon 1, has enabled him to delve deeply into the complexities of physical medicine and rehabilitation (PMR). It was during this phase that Dr. Rode developed an interest in combining clinical work with cutting-edge research, exploring the rehabilitation processes from both medical and scientific perspectives.

Professional Endeavors 🏥


In his professional career, Dr. Rode has held pivotal roles in both clinical and academic settings. Since 2009, he has served as the Head of the Department of Rehabilitation at Hôpital Henry Gabrielle, part of the Hospices Civils de Lyon. This role allowed him to shape the development of rehabilitation practices within a leading French hospital. Furthermore, between 2009 and 2016, he contributed significantly as the Vice-Dean at the Faculty of Medicine Lyon-Est, Université Claude Bernard Lyon 1, a position that gave him a platform to influence medical education. His leadership and vision have consistently propelled the field forward, particularly in the integration of advanced rehabilitation techniques into patient care.

Contributions and Research Focus 🔬

Dr. Rode’s research has consistently focused on enhancing physical rehabilitation methods, particularly for individuals recovering from neurological impairments. His scientific inquiries are centered on understanding the mechanisms of neuroplasticity and recovery in brain-injured patients. As a leading member of the Centre de Recherche en Neurosciences de Lyon, his work integrates neuroscience with rehabilitation science, aiming to improve clinical practices and outcomes. His pioneering studies on motor rehabilitation and the use of innovative techniques for brain injury recovery have earned him recognition within both the scientific and medical communities.

Accolades and Recognition 🏅


Dr. Rode’s commitment to advancing the field of physical medicine and rehabilitation has been recognized through numerous accolades. He served as the President of the French Society of Physical Medicine and Rehabilitation (Sofmer) from 2013 to 2016, a position that allowed him to advocate for the integration of contemporary rehabilitation approaches in French healthcare. In 2015, he was elected as a member of the European Academy of Rehabilitation and Physical Medicine, further cementing his status as a leader in the field. His leadership roles and scientific contributions have earned him significant recognition both nationally and internationally.

Impact and Influence 🌍


Dr. Rode’s impact extends far beyond his clinical and academic roles. His work has influenced policies in rehabilitation medicine and has set standards for how rehabilitation should be practiced in hospital settings. As the Dean of the Faculty of Medicine Lyon-Est, he has been at the forefront of shaping medical curricula to ensure that the next generation of doctors is well-equipped to address the challenges of rehabilitation medicine. His ability to bridge the gap between research and clinical practice has resulted in more effective therapies and patient outcomes, impacting countless lives.

Legacy and Future Contributions 🔮


As Dr. Rode continues his work, his legacy is one of both clinical excellence and scientific innovation. His research has had a lasting effect on how physical medicine and rehabilitation are perceived in the medical community. Moving forward, Dr. Rode is expected to continue influencing the development of rehabilitation therapies, particularly in the areas of neuroplasticity and motor recovery. His future contributions will undoubtedly build on the foundation he has established, ensuring that patients continue to benefit from the evolving advancements in rehabilitation medicine.

Global Influence and Leadership 🌐


Dr. Rode’s reputation extends beyond the borders of France, as he is often invited to share his expertise at international conferences and seminars. His leadership in both academia and professional societies has made him a global voice in rehabilitation. Through his active involvement in the European Academy of Rehabilitation and Physical Medicine, he continues to contribute to the global exchange of ideas, driving the evolution of rehabilitation practices across Europe and beyond. Dr. Rode’s influence is not just felt in France but is also shaping the future of rehabilitation medicine worldwide.

Publication

  • Title: Determining the influence of a sleep improvement intervention on medical students’ sleep and fatigue: protocol of the PROMESS-Sleep clinical trial
    Authors: Ruet, Axelle; Ndiki Mayi, Evrard Florentin; Métais, Angèle; Rode, Gilles; Schlatter, Sophie T.
    Year: 2025

 

  • Title: Determining the influence of an intervention of stress management on medical students’ levels of psychophysiological stress: the protocol of the PROMESS-Stress clinical trial
    Authors: Métais, Angèle; Omarjee, Mohammad; Valero, Bérénice; Rode, Gilles; Schlatter, Sophie T.
    Year: 2025

 

  • Title: Co-administration of methylphenidate and prism adaptation would require striatal integrity to alleviate spatial neglect: A preliminary study
    Authors: Beaudoin-Gobert, Maude; Benistant, Faustine; de Lanversin, Maxence; Rossetti, Yves; Luauté, Jacques
    Year: 2024 (presumed, not listed but grouped contextually)

 

  • Title: Updates on post-stroke rehabilitation
    Authors: Charbonnier, Geoffroy; Bihel, Lucie; Jacquin-Courtois, Sophie; Rode, Gilles; Mateo, Sébastien
    Year: 2024 (presumed)

 

  • Title: Effect of coping interventions on performance of medical students during objective structured clinical examination: A randomized controlled trial
    Authors: Schlatter, Sophie T.; Berland, Alexandre; Lutz, Antoine; Rode, Gilles; Lilot, Marc E.
    Year: 2025

 

  • Title: Associations of coping and health-related behaviors with medical students’ well-being and performance during objective structured clinical examination
    Authors: Barret, Noémie; Guillaumée, Théodore; Rimmelé, Thomas R.; Lilot, Marc E.; Schlatter, Sophie T.
    Year: 2024

 

  • Title: Grasping rehabilitation using motor imagery with or without neurofeedback after tetraplegia: A study protocol for a bicentric randomised controlled trial
    Authors: Charbonnier, Geoffroy; Reilly, Karen T.; Schwartz, Denis P.; Rode, Gilles; Mateo, Sébastien
    Year: 2024

 

  • Title: Neck muscle vibration and prism adaptation fail to improve balance disturbances after stroke: A multicentre randomised controlled study
    Authors: Leplaideur, Stephanie; Allart, Etienne; Chochina, Lucie; Bannier, Élise; Bonan, Isabelle Véronique
    Year: 2024

 

  • Title: Striking the Balance: Embracing Technology While Upholding Humanistic Principles in Neurorehabilitation
    Authors: Ardaillon, Hugo; Ribault, Shams; Herault, Caroline; Reilly, Karen T.; Rode, Gilles
    Year: 2024

 

  • Title: Implicit and explicit motor imagery ability after SCI: Moving the elbow makes the difference
    Authors: Mateo, Sébastien; Guillot, Aymeric; Henkous, Sonia; Collet, Christian; Di Rienzo, Franck
    Year: 2024

 

Conclusion


Dr. Gilles Rode’s work has left an indelible mark on the field of rehabilitation, where his contributions have influenced both clinical practices and academic curricula. His dedication to improving patient outcomes through innovative rehabilitation methods, combined with his leadership and advocacy in professional societies, ensures that his influence will continue for years to come. As he progresses in his career, Dr. Rode remains a key figure in advancing the field of physical medicine and rehabilitation, shaping both the future of patient care and the next generation of healthcare professionals. His legacy will continue to inspire progress in rehabilitation science, benefiting countless individuals across the globe.

Peng Jun | Cellular Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Prof. Peng Jun | Cellular Neuroscience | Best Researcher Award

Prof. Peng Jun, Qilu hospital of Shandong University, China.

Professor Jun Peng is a distinguished leader in hematology, currently serving as Vice President of Qilu Hospital of Shandong University and Director of the Department of Hematology. His research is deeply rooted in the immunological pathogenesis and immune tolerance of primary immune thrombocytopenia (ITP), where he has made significant breakthroughs, including the publication of 14 papers in Blood. With a career supported by prestigious national awards, and leadership in 15 high-level research projects, Professor Peng is also a vital figure in Chinese hematology societies and editorial boards of leading journals. His academic rigor, clinical insight, and mentorship continue to shape the future of hematological science in China and beyond.

Profile

Scopus

🎓 Early Academic Pursuits

Professor Jun Peng embarked on his academic journey with a strong commitment to medicine and hematological sciences. From the outset, he exhibited exceptional academic talent and dedication, leading him to pursue both an M.D. and Ph.D. His early education laid a robust foundation for his future specialization in hematology, particularly in the complex field of immunological disorders. His doctoral work, recognized nationally, foreshadowed the groundbreaking contributions he would later make in immune thrombocytopenia research.

🩺 Professional Endeavors

Currently serving as the Vice President of Qilu Hospital of Shandong University, Professor Peng also holds the roles of Chief Physician, Professor, and Ph.D./M.D. Advisor, in addition to being the Director of the Department of Hematology. His clinical and academic responsibilities are carried out with unwavering diligence, mentoring future medical experts while overseeing high-level clinical operations. As a Distinguished Professor of Shandong University, he is actively engaged in shaping the university’s medical excellence on both national and global stages.

🔬 Contributions and Research Focus

At the heart of Professor Peng’s career is his pioneering work on the immunological pathogenesis and immune tolerance of primary immune thrombocytopenia (ITP). He has made substantial contributions to understanding the autoimmune mechanisms that underlie ITP, one of the most challenging hematologic disorders. His scholarly dedication is evidenced by the publication of 14 papers in Blood, a leading journal in hematology, where he served as corresponding or co-corresponding author. His research, grounded in clinical insight and scientific precision, has contributed new perspectives on immune regulation in hematologic diseases.

🏆 Accolades and Recognition

Professor Peng’s excellence has been recognized with numerous prestigious awards. These include the National Science Fund for Distinguished Young Scholars, which highlights his scientific creativity and impact at a young age. He is also a recipient of the One-Hundred National Outstanding Doctoral Dissertation Award, a testament to the academic rigor of his early research. Additionally, he earned the First Prize of the Natural Science Award for Outstanding Achievements in Scientific Research from the Ministry of Education and the Science and Technology Progress Award, reflecting both his academic brilliance and practical impact in the medical field.

🧪 Impact and Influence

Beyond research publications, Professor Peng has significantly influenced the broader scientific and medical communities. As a principal investigator, he has led fifteen national and ministerial-level research projects, including those funded by the National Natural Science Foundation of China and the 973 Program under the Ministry of Science and Technology. His leadership extends to active roles in national academic societies, including the Thrombosis and Hemostasis Group of the Chinese Society of Hematology and the Professional Committee of Experimental Hematology of the Chinese Society of Pathophysiology. These positions allow him to shape the direction of hematological research and clinical guidelines in China.

📚 Academic Leadership and Editorial Roles

A passionate advocate for knowledge dissemination, Professor Peng is a key editorial board member for several respected journals such as Thrombosis Journal, Thrombosis Research, Journal of Clinical Hematology, and the Chinese Journal of Hematology. Through these roles, he ensures that cutting-edge research in hematology is critically evaluated and shared widely, fostering a culture of scientific excellence and collaboration across the globe.

🌟 Legacy and Future Contributions

Professor Jun Peng’s legacy is being forged not only through his past achievements but also through his continued commitment to the advancement of hematological science. His influence spans clinical innovation, academic mentorship, and scientific discovery. As he continues to push the boundaries of understanding in ITP and immune tolerance, he inspires a new generation of physician-scientists. The impact of his work promises to resonate for years to come, offering hope and healing for patients and propelling China’s medical research onto the world stage.

Publication

  • Title: Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)
    Authors: Qizhao Li, Geneviève Marcoux, Yuefen Hu, Jung Peng, John W. Semple
    Year: 2024

 

  • Title: Quantitative detection of macular microvascular abnormalities identified by optical coherence tomography angiography in different hematological diseases
    Authors: Tianzi Jian, Fabao Xu, Guihua Li, Li Zhang, Jung Peng
    Year: 2024

 

  • Title: Nicotinamide enhances Treg differentiation by promoting Foxp3 acetylation in immune thrombocytopenia
    Authors: Ju Li, Cheng Zhang, Yuefen Hu, Qi Feng, Xiang Hu
    Year: 2024

 

  • Title: The effects of complement-independent, autoantibody-induced apoptosis of platelets in immune thrombocytopenia (ITP)
    Authors: Lin Sun, Yichen Zhang, Ping Chen, Jung Peng, Zi Sheng
    Year: 2024

 

  • Title: Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic review
    Authors: You Yuan Su, Yafei Yu, Zhenyu Yan, Jung Peng, Xinguang Liu
    Year: 2024

 

  • Title: Ion channel Piezo1 activation aggravates the endothelial dysfunction under a high glucose environment
    Authors: Xiaoyu Zhang, Shaoqiu Leng, Xinyue Liu, Shuwen Wang, Jung Peng
    Year: 2024

 

  • Title: Intelligent dual-modality label-free cell classification with light scattering imaging and Raman spectra measurements
    Authors: Faihaa Mohammed Eltigani, Xiaoyu Zhang, Min Liu, Jung Peng, Xuantao Su
    Year: 2024

 

  • Title: Eltrombopag plus diacerein vs eltrombopag in patients with ITP: a multicenter, randomized, open-label phase 2 trial
    Authors: Lu Sun, Xiaoyang Huang, Juan Wang, Ming Hou, Yu Hou
    Year: 2024

 

  • Title: Risk Factors for Mortality in Critically Ill Patients with Coagulation Abnormalities: A Retrospective Cohort Study
    Authors: Qiuyu Guo, Jung Peng, Tichao Shan, Miao Xu
    Year: 2024

 

  • Title: Platelet-derived TGF-β1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia
    Authors: Lingjun Wang, Haoyi Wang, Mingfang Zhu, Ming Hou, Yu Hou
    Year: 2024

 

✅ Conclusion

Through his pioneering research, unwavering clinical dedication, and impactful academic leadership, Professor Jun Peng stands at the forefront of immuno-hematology. His work not only deepens scientific understanding of ITP but also contributes directly to improved patient outcomes. As he continues to inspire through teaching, research, and innovation, Professor Peng’s legacy is one of excellence, influence, and ongoing transformation in the global hematology community.

 

Handrean Soran | Clinical Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Prof. Handrean Soran | Clinical Neuroscience | Best Researcher Award

Prof. Handrean Soran,  Manchester University NHS Foundation Trust, United Kingdom.

Dr. Handrean Soran is a distinguished British endocrinologist and researcher with expertise in diabetes, endocrinology, and cardiovascular diseases. His academic journey began in Iraq and advanced through the UK, where he earned prestigious medical qualifications, including an MD in Medicine and MSc in Diabetes and Endocrinology. Throughout his career, Dr. Soran has contributed significantly to research on the relationship between diabetes and cardiovascular health, publishing extensively in high-impact journals like The New England Journal of Medicine and Lancet. His work has garnered global recognition, including an H-index of 49 and numerous accolades, solidifying his position as a leader in his field.

Profile

Google Scholar

 

Early Academic Pursuits 📚

Handrean Soran’s academic journey began in the Kurdistan region of Iraq, where he completed his A-levels with an impressive score of 94.5% from Sulemani High School in 1985. His drive for knowledge led him to pursue his MBChB at Al-Mustansyria University in Baghdad, Iraq, graduating in 1990. This foundational education set the stage for a career dedicated to medical research and practice. After completing his medical degree, he pursued further specialized training in the UK, where he earned his MRCP from the Royal College of Physicians in Edinburgh in 1999, and later, an MSc in Diabetes and Endocrinology from the University of Liverpool in 2006. These early academic milestones laid the foundation for his later expertise in endocrinology and diabetes, fields that would define his career.

Professional Endeavors 🏥

Dr. Handrean Soran’s professional journey is marked by a dedication to medicine, particularly in the fields of endocrinology and diabetes. He has held significant roles in prestigious institutions, with his current position in the Department of Diabetes, Endocrinology, and Metabolism at Manchester University Hospitals NHS Foundation Trust. His medical career was further enhanced by his qualifications as a Fellow of the Royal College of Physicians (FRCP) from both Glasgow and Edinburgh. Throughout his career, Dr. Soran has worked on developing innovative approaches in clinical care and research, constantly striving to improve patient outcomes and advancing medical knowledge.

Contributions and Research Focus 🔬

Dr. Soran’s research focus primarily centers on diabetes, endocrinology, and cardiovascular health, specifically the interplay between metabolic disorders and heart disease. His research efforts have been integral to understanding the link between diabetes and cardiovascular risk, with a significant body of work examining the effects of treatments on these interconnected conditions. His contributions have been recognized through multiple high-impact publications in renowned journals such as the New England Journal of Medicine, Lancet, and European Heart Journal. With an H-index of 49 and over 130 citations, Dr. Soran’s work continues to shape the clinical landscape in these areas, driving further advancements in treatment protocols and therapeutic strategies for diabetes and cardiovascular diseases.

Accolades and Recognition 🏆

Dr. Soran’s career has been decorated with numerous accolades, affirming his status as a leader in his field. He achieved the prestigious title of Fellow of the Royal College of Physicians (FRCP) in both Edinburgh and Glasgow, a testament to his clinical expertise and contribution to medical science. His groundbreaking work in diabetes and cardiovascular research has earned him recognition not only from peers but also from major medical institutions. His publications in top-tier journals further highlight his academic prowess, solidifying his position as a key thought leader in the medical and academic communities.

Impact and Influence 🌍

Dr. Handrean Soran’s work extends beyond the realm of research publications; it has made a lasting impact on the clinical management of diabetes and cardiovascular diseases worldwide. His insights have contributed to shaping healthcare policies and clinical practices, particularly in the management of diabetic patients at high cardiovascular risk. Through his collaboration with the Division of Cardiovascular Sciences at the University of Manchester, he has fostered interdisciplinary approaches to solving complex medical challenges, advancing the integration of cardiovascular care with endocrinology. His work has influenced not only academic circles but also clinical practice, providing new directions for patient care.

Legacy and Future Contributions 🌱

As Dr. Soran continues his impactful work, his legacy is one of dedication to improving patient health outcomes and advancing the fields of endocrinology and diabetes. With a deep commitment to teaching and mentorship, Dr. Soran plays a pivotal role in training the next generation of doctors and researchers. His future contributions are poised to further explore the intricate relationship between metabolic disorders and cardiovascular health, addressing the growing global burden of these interconnected diseases. His work will undoubtedly continue to guide both clinical practice and future research in endocrinology, diabetes, and cardiovascular medicine, ensuring his ongoing influence in these critical areas.

Global Recognition and Influence 🌐

Dr. Soran’s influence reaches across borders, as evidenced by his extensive publication record and recognition within the global medical community. His research has not only enriched the scientific literature but also contributed to global health initiatives, particularly in the area of metabolic disorders and cardiovascular diseases. With collaborations spanning multiple continents, Dr. Soran is dedicated to improving health outcomes globally, offering expert insights into the prevention and management of diabetes and heart disease. His role in shaping clinical guidelines and his participation in international research collaborations further amplify his global impact.

Academic and Professional Leadership 🎓

In addition to his research contributions, Dr. Soran’s leadership within academia is profound. He holds multiple academic positions, including his affiliation with the University of Manchester, where he plays an integral role in advancing research within the Division of Cardiovascular Sciences. His leadership extends to mentoring young researchers and clinicians, helping to foster a new generation of experts in endocrinology and diabetes. Dr. Soran’s academic vision continues to drive progress in both education and research, making significant strides in improving how diabetes and cardiovascular diseases are understood and treated. His future work promises to leave a lasting mark on medical education and the advancement of scientific knowledge.

Publication

  • Cardiovascular efficacy and safety of bococizumab in high-risk patients
    Author: PM Ridker
    Year: 2017

 

  • Volanesorsen and triglyceride levels in familial chylomicronemia syndrome
    Author: JL Witztum
    Year: 2019

 

  • Triglyceride lowering with pemafibrate to reduce cardiovascular risk
    Author: A Das Pradhan
    Year: 2022

 

  • Diabetes dyslipidemia
    Author: JD Schofield
    Year: 2016

 

  • Lysosomal acid lipase deficiency–an under-recognized cause of dyslipidaemia and liver dysfunction
    Author: Ž Reiner
    Year: 2014

 

  • Obesity: a critical risk factor in the COVID‐19 pandemic
    Author: S Kwok
    Year: 2020

 

  • Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
    Author: KK Ray
    Year: 2019

 

  • Hypercholesterolaemia and its management
    Author: D Bhatnagar
    Year: 2008

 

  • Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
    Author: B Williams
    Year: 2018

 

  • Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset …
    Author: FJ Raal
    Year: 2017

 

Conclusion

Dr. Handrean Soran’s career is marked by profound contributions to medical science, particularly in the fields of diabetes and cardiovascular health. His groundbreaking research and clinical expertise have had a significant impact on both academic and healthcare practices worldwide. As a recognized leader in his field, Dr. Soran’s work continues to influence the management of metabolic and cardiovascular diseases, and his future contributions promise to further advance these critical areas of medical research and practice. His legacy is one of dedication, leadership, and a commitment to improving health outcomes globally.